Clinical Characteristics and Karyotype Analysis of Myelodysplastic Syndrome Patients with TP53 mutation.
10.19746/j.cnki.issn.1009-2137.2019.03.038
- Author:
Xu-Yan ZHOU
1
;
Gui-Fang OUYANG
2
,
3
;
Qi-Tian MU
1
;
Li-Xia SHENG
1
Author Information
1. Department of Hematology, Ningbo First Hospital Affiliated to Ningbo University Medical College, Ningbo 315000, Zhejiang Province, China.
2. Department of Hematology, Ningbo First Hospital Affiliated to Ningbo University Medical College, Ningbo 315000, Zhejiang Province, China,E-mail: nbougf@
3. com.
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Aged, 80 and over;
Female;
Humans;
Karyotype;
Karyotyping;
Male;
Middle Aged;
Mutation;
Myelodysplastic Syndromes;
genetics;
Prognosis;
Retrospective Studies;
Tumor Suppressor Protein p53;
genetics;
Young Adult
- From:
Journal of Experimental Hematology
2019;27(3):872-876
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the clinical characteristics of myelodysplastic syndrome (MDS) with TP53 mutant and the relationship between TP53 mutation and monosomal karyotype in MDS patients.
METHODS:The TP53 mutations in 102 patients with de nove MDS were retrospectively analyzed, and the clinical features of the TP53 mutation group and the non-mutation group were compared. The relationship between TP53 mutation and karyotype, especially monosomal karyotype was analyzed.
RESULTS:Fifty-two out of the 102 MDS patients were male and 50 were female, the median age was 59.5 (23-83) years old. The mutational frequency of TP53 was 12.7%, which mostly occurred in patients with MDS-EB. As compared with non-mutation group, the hemoglobin level and platelet count were lower (P=0.001, P=0.033), the LDH level and bone marrow blast ratio were higher in TP53 mutation group (P=0.002, P＜0.001), but the statistical difference of alsolute count of neutrophils and levels of serum ferritin and β2-microglobulin between 2 groups was not found. The karyotype abnormality frequency of patients with TP53 mutation was 90.9%, among them 72.7% was monosomal karyotype. The incidence of monosomal karyotype in the TP53 mutation group was very significantly higher than that in the non-mutation group (P＜0.001). MDS with TP53 mutation and monosomal karyotype appeared in the groups with high and very high IPSS-R risk.
CONCLUSION:MDS patients with TP53 mutation have unique clinical features and high incidence of monosomal karyotype, and their overall prognosis is poor.
